Sutro Biopharma, Inc. (STRO)
10.65
-0.68
(-6.00%)
USD |
NASDAQ |
Jan 13, 16:00
10.65
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Research and Development Expense (Quarterly): 39.85M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| GT Biopharma, Inc. | 0.634M |
| Daré Bioscience, Inc. | 0.6933M |
| Syndax Pharmaceuticals, Inc. | 56.28M |
| Crinetics Pharmaceuticals, Inc. | 89.45M |
| NovaBay Pharmaceuticals, Inc. | -- |